A Concept for the Reduction of Mucosal SARS-CoV-2 Load using Hypochloric Acid Solutions

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

Abstract

During the next few months or years, vaccination against SARS-CoV-2 infection will significantly reduce the morbidity and mortality of COVID-19. However, additional measures are needed to protect those who are still not immunized. This is even more important in view of new viral mutations that result in increased transmission rates. We propose that the use of long-standing medicinal solutions based on hypochloric acid (HOCl) and intended for application on wounds may be effective as a gargling solution or nasal irrigation in blocking transmission of the virus. Here, we propose the use of HOCl-containing solutions for blocking the transmission of SARS-CoV-2 in combination with other prevention measures. This may constitute another important cornerstone in the fight against the COVID-19 pandemic.

Details

Original languageEnglish
Pages (from-to)348-350
Number of pages3
Journal Drug research : discovery, development, evaluation, translational medicine
Volume71
Issue number6
Publication statusPublished - 1 Jul 2021
Peer-reviewedYes

External IDs

PubMed 33890267
ORCID /0000-0003-0845-6793/work/139025236

Keywords

Sustainable Development Goals

ASJC Scopus subject areas